Top Markets
#1 0G 0G +41.62%
#2 Useless Coin Useless Coin +37.69%
#3 Merlin's Seal BTC Merlin's Seal BTC +37.35%
#4 SAFEcoin SAFEcoin +29.70%
#5 Arbitrum Arbitrum +28.39%
#6 StonkBroker StonkBroker +27.25%
#7 Pons Pons +22.09%
#8 Notcoin Notcoin +20.52%
#9 Zora Zora +18.90%
#10 Full Moon Full Moon +18.20%
Coin of the day
0G 0G
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Evommune, Inc. Evommune, Inc.

Evommune, Inc.

EVMN
Clasificación en acciones #13821
Evommune, Inc. is a United States-based clinical-stage biotechnology company... Evommune, Inc. is a United States-based clinical-stage biotechnology company dedicated to advancing novel therapeutic solutions. Their primary focus lies in addressing the underlying mechanisms of chronic inflammatory diseases. Initial clinical development efforts are concentrated on conditions such as chronic spontaneous urticaria, atopic dermatitis, and ulcerative colitis. The company's investigational portfolio features EVO756, which is being developed for the treatment of chronic spontaneous urticaria (CSU) and atopic dermatitis (AD), and EVO301, intended for atopic dermatitis (AD) and ulcerative colitis (UC). Established in 2020, Evommune operates from its headquarters in Palo Alto, California.
Precio por acción
$12.63
Capitalización bursátil
$458.19M
Cambio (1 día)
-3.26%
Cambio (1 año)
-
País
US
Comercio Evommune, Inc. (EVMN)

Categoría

Healthcare
Ratio P/S de Evommune, Inc. (EVMN)
Ratio P/S al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Evommune, Inc., el ratio P/S actual (TTM) es 0. Al final de 2026, el ratio P/S era 0.
Historial del ratio P/S de Evommune, Inc. desde 2026 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
Not enough data for the provided dates.
Ratio P/S de empresas similares o competidoras
Empresa Ratio P/S Diferencia del ratio P/S País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH